In vitro activity of tigecycline and 10 other antimicrobials against clinical isolates of the genus Corynebacterium

International Journal of Antimicrobial Agents

Volumn 33, Issue 5, 2009, Pages 453-455

  Fernandez Roblas, R ^a   Adames, H ^a   Martin de Hijas N Z ^a   Garcia Almeida D ^a   Gadea, I ^a   Esteban, J ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Corynebacterium; MIC; Susceptibility; Tigecycline

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GLYCOPEPTIDE; LINEZOLID; MACROLIDE; PENICILLIN G; RIFAMPICIN; TIGECYCLINE; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CORYNEBACTERIUM; CORYNEBACTERIUM AFERMENTANS; CORYNEBACTERIUM AMYCOLATUM; CORYNEBACTERIUM AURIMUCOSUM; CORYNEBACTERIUM COYLAEA; CORYNEBACTERIUM INFECTION; CORYNEBACTERIUM JEIKEIUM; CORYNEBACTERIUM STRIATUM; CORYNEBACTERIUM UREALYTICUM; EPSILOMETER TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CORYNEBACTERIUM; CORYNEBACTERIUM INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE;

EID: 62949143591     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.11.001     Document Type: Article

References (17)

1. Funke G., von Graevenitz A., Clarridge III J.E., and Bernard K.A. Clinical microbiology of coryneform bacteria. Clin Microbiol Rev 10 (1997) 125-159
2. Belmares J., Detterline S., Pak J.B., and Parada J.P. Corynebacterium endocarditis species-specific risk factors and outcomes. BMC Infect Dis 7 (2007) 4
3. von Graevenitz A., Frommelt L., Pünter-Streit V., and Funke G. Diversity of coryneforms found in infections following prosthetic joint insertion and open fractures. Infection 26 (1998) 36-38
4. Funke G., Pünter V., and von Graevenitz A. Antimicrobial susceptibility patterns of some recently established coryneform bacteria. Antimicrob Agents Chemother 40 (1996) 2874-2878
5. Pankey G.A. Tigecycline. J Antimicrob Chemother 56 (2005) 470-480
6. Stein G.E., and Craig W.A. Tigecycline: a critical analysis. Clin Infect Dis 43 (2006) 518-524
7. Salas C., Calvo J., and Martinez-Martinez L. Activity of tigecycline against coryneform bacteria of clinical interest and Listeria monocytogenes. Antimicrob Agents Chemother 52 (2008) 1503-1505
8. Esteban J., Nieto E., Calvo R., Fernández-Roblas R., and Soriano F. Microbiological characterization and clinical significance of Corynebacterium amycolatum strains. Eur J Clin Microbiol Infect Dis 18 (1999) 518-521
9. Fernández-Natal M.I., Sáez-Nieto J.A., Fernández-Roblas R., Asencio M., Valdezate S., Lapeña S., et al. The isolation of Corynebacterium coyleae from clinical samples: clinical and microbiological data. Eur J Clin Microbiol Infect Dis 27 (2008) 177-184
10. Bolmström A., Karlsson A., Engelhardt A., Ho P., Petersen P.J., Bradford P.A., et al. Validation and reproducibility assessment of tigecycline MIC determinations by Etest. J Clin Microbiol 45 (2007) 2474-2479
11. Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved standard. Document M45-A. Wayne, PA: CLSI; 2006.
12. Soriano F., and Tauch A. Microbiological and clinical features of Corynebacterium urealyticum: urinary tract stones and genomics as the Rosetta Stone. Clin Microbiol Infect 14 (2008) 632-643
13. Babay H.A., and Kambal A.M. Isolation of coryneform bacteria from blood cultures of patients at a university hospital in Saudi Arabia. Saudi Med J 25 (2004) 1073-1079
14. Yassin A.F., Steiner U., and Ludwig W. Corynebacterium aurimucosum sp. nov. and emended description of Corynebacterium minutissimum Collins and Jones (1983). Int J Syst Evol Microbiol 52 (2002) 1001-1005
15. Hope R., Parsons T., Mushtaq S., James D., and Livermore D.M. Determination of disc breakpoints and evaluation of Etests for tigecycline susceptibility testing by the BSAC method. J Antimicrob Chemother 60 (2007) 770-774
16. Kronvall G., Karlsson I., Walder M., Sörberg M., and Nilsson L.E. Epidemiological MIC cut-off values for tigecycline calculated from Etest MIC values using normalized resistance interpretation. J Antimicrob Chemother 57 (2006) 498-505
17. Martín-de-Hijas N.Z., Fernández Roblas R., Fernández Martínez A.I., Gadea I., and Esteban J. Usefulness of Etest to study tigecycline susceptibility for non-pigmented rapidly growing mycobacteria. Int J Antimicrob Agents 32 (2008) 366-367